Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 25
Filter
Add more filters










Publication year range
1.
Mol Biol (Mosk) ; 57(6): 1006-1016, 2023.
Article in Russian | MEDLINE | ID: mdl-38062956

ABSTRACT

The aim of this work was to study the effects of thymosin-1 alpha (Tα1) on the anti-inflammatory response of RAW 264.7 macrophages cultured in the presence of lipopolysaccharide (LPS) from the walls of gram-negative bacteria. As well, we evaluated production of pro-inflammatory cytokines and the activity of the NF-κB and SAPK/JNK signaling pathways. In addition, the level of expression of a number of genes that regulate cell apoptosis, as well as the activity of receptors involved in the pro-inflammatory response, was determined. First, the addition of Tα1 normalized the level of cytokine production to varying degrees, with a particularly noticeable effect on IL-1ß and IL-6. Second, the addition of Tα1 normalized the activity of the NF-κB and SAPK/JNK signaling cascades and the expression of the Tlr4 gene. Third, Tα1 significantly reduced p53 and the activity of the P53 gene, which is a marker of cell apoptosis. Fourth, it was shown that the increase in Ar-1 gene expression under the influence of LPS was significantly reduced using Tα1. Thus, it was found that the presence of Tα1 in the RAW 264.7 cell culture medium significantly reduced the level of the pro-inflammatory response of cells.


Subject(s)
NF-kappa B , Thymosin , Animals , Mice , NF-kappa B/genetics , NF-kappa B/metabolism , RAW 264.7 Cells , Endotoxins , Lipopolysaccharides/pharmacology , Thymosin/genetics , Thymosin/pharmacology , Cytokines/metabolism
2.
Mol Biol (Mosk) ; 57(6): 1150-1174, 2023.
Article in Russian | MEDLINE | ID: mdl-38062966

ABSTRACT

Ischemia-reperfusion is a cascade of complex and interrelated pathological processes underlying many human diseases, including such socially significant diseases as stroke, myocardial infarction, acute renal failure, etc. The present review considers modern ideas about the main biochemical and signal-regulatory processes in the cell under conditions of ischemia-reperfusion. Both generally accepted and newly developed ways of ischemia-reperfusion lesion correction aimed at different chains of this pathological process are considered.


Subject(s)
Myocardial Infarction , Myocardial Reperfusion Injury , Reperfusion Injury , Humans , Myocardial Reperfusion Injury/genetics , Signal Transduction , Reperfusion Injury/genetics , Reperfusion Injury/pathology , Oxidative Stress
3.
Arch Biochem Biophys ; 746: 109729, 2023 09 15.
Article in English | MEDLINE | ID: mdl-37633587

ABSTRACT

This study aimed to assess the effects of the immunomodulator thymulin, a thymic peptide with anti-inflammatory effects, and peroxiredoxin 6 (Prdx6), an antioxidant enzyme with dual peroxidase and phospholipase A2 activities, on the blood‒brain barrier (BBB) condition and general health status of animals with relapsing-remitting experimental autoimmune encephalomyelitis (EAE), which is a model of multiple sclerosis in humans. Both thymulin and Prdx6 significantly improved the condition of the BBB, which was impaired by EAE induction, as measured by Evans blue dye accumulation, tight-junction protein loss in brain tissue, and lymphocyte infiltration through the BBB. The effect was associated with significant amelioration of EAE symptoms. Thymulin treatment was accompanied by a decrease in immune cell activation as judged by interleukin-6, -17, and interferon-gamma cytokine levels in serum and NF-kappaB cascade activation in splenocytes of mice with EAE. Prdx6 did not induce significant immunomodulatory effects but abruptly decreased EAE-induced NOX1 and NOX4 gene expression in brain tissue, which may be one of the possible mechanisms of its beneficial effects on BBB conditions and health status. The simultaneous administration of thymulin and Prdx6 resulted in complete symptomatic restoration of mice with EAE. The results demonstrate prospective strategies for multiple sclerosis treatment.


Subject(s)
Encephalomyelitis, Autoimmune, Experimental , Multiple Sclerosis , Animals , Humans , Mice , Blood-Brain Barrier , Encephalomyelitis, Autoimmune, Experimental/drug therapy , Models, Theoretical , Multiple Sclerosis/drug therapy , Peroxiredoxin VI , Prospective Studies , Thymic Factor, Circulating/pharmacology , Thymic Factor, Circulating/therapeutic use
4.
Dokl Biochem Biophys ; 506(1): 202-205, 2022 Oct.
Article in English | MEDLINE | ID: mdl-36303052

ABSTRACT

The aim of the study was to evaluate the possibility of increasing the radioprotective potential of peroxiredoxin 6 (Prdx6) and its mutant form S32A by their combined use with geldanamycin (GA) for 3T3 fibroblasts irradiated with X-rays at a dose of 6 Gy. The mutant enzyme S32A, which does not have phospholipase activity, exhibits a more pronounced radioprotective activity when combined with GA. The use of this combination of radioprotective drugs completely abolishes the peak of NF-κB activity in irradiated 3T3 cells. Another transcription factor, p53, which is an indicator of the level of cell apoptosis and increases upon irradiation, is also reduced by S32A in combination with GA. The low-molecular-weight protein p21, which is a marker of cell senescence and whose production increases upon irradiation, is also normalized when S32A is used in combination with GA. In addition, the use of this combination of radioprotective drugs significantly reduces the stress response of 3T3 cells to X-ray irradiation.


Subject(s)
Radiation-Protective Agents , Mice , Animals , Radiation-Protective Agents/pharmacology , Lactams, Macrocyclic , Benzoquinones/pharmacology , Fibroblasts
5.
Bull Exp Biol Med ; 169(2): 224-228, 2020 Jun.
Article in English | MEDLINE | ID: mdl-32654002

ABSTRACT

We analyzed structural and functional features of the main mitochondrial Ca2+-transporting systems, mitochondrial Ca2+ uniporter complex (MCUC) and Ca2+-dependent cyclosporin A-sensitive mitochondrial permeability transition pore (MPT pore), in rats with hyperthyroid state. It was found that, the rate of Ca2+ accumulation by rat liver mitochondria in this pathology increases by 1.3 times, which can be associated with higher level of the channel-forming subunit of the uniporter MCU and lower content of dominant-negative subunit of this complex MCUb. At the same time, the level of the regulatory subunit MICU1 remained unchanged. It was shown that calcium retention capacity of liver mitochondria in rats with experimental hyperthyroidism decreased by 2 times in comparison with the control, which attested to reduced resistance of liver mitochondria of hyperthyroid rats to induction of the MPT pore. The observed changes are consistent with the data on increased amount of cyclophilin D, a mitochondrial matrix peptidyl-prolyl isomerase that is known to modulate the MPT pore opening and expression of the Ppif gene that encodes mitochondrial cyclophilin D in rats with experimental hyperthyroidism.


Subject(s)
Calcium Channels/metabolism , Hyperthyroidism/metabolism , Mitochondria, Liver/metabolism , Mitochondrial Membrane Transport Proteins/metabolism , Animals , Calcium/metabolism , Peptidyl-Prolyl Isomerase F/metabolism , Male , Mitochondrial Permeability Transition Pore/metabolism , Rats , Rats, Wistar
6.
Cell Tissue Res ; 378(2): 319-332, 2019 Nov.
Article in English | MEDLINE | ID: mdl-31363842

ABSTRACT

Peroxiredoxin 6 (Prx6) is an important antioxidant enzyme with various functions in the cell. Prx6 reduces a wide range of peroxide substrates, playing a leading role in maintaining the redox homeostasis of mammalian cells. In addition to the peroxidase activity, a phospholipase A2-like activity was demonstrated for Prx6, which plays an important role in the metabolism of membrane phospholipids. Besides that, due to its peroxidase and phospholipase activities, Prx6 participates in intracellular and intercellular signal transduction, thus triggering regenerative processes in the cell, suppressing apoptosis caused by various factors, including ischemia-reperfusion injuries. A nephroprotective effect of exogenous recombinant Prx6 administered before ischemia-reperfusion injury was demonstrated on an animal model. Exogenous Prx6 effectively alleviates the severeness of renal ischemia-reperfusion injuries and facilitates normalization of their structural and functional conditions. Infusion of exogenous Prx6 increases the survival rate of experimental animals by almost 3 times. Application of exogenous Prx6 can be an effective approach in the prevention and treatment of renal ischemia-reperfusion kidney lesions and in preserving isolated kidneys during transplantation.


Subject(s)
Kidney , Oxidative Stress/drug effects , Peroxiredoxin VI/pharmacology , Protective Agents/pharmacology , Reperfusion Injury/drug therapy , Animals , Disease Models, Animal , Kidney/drug effects , Kidney/pathology , Mice, Inbred BALB C , Recombinant Proteins/pharmacology , Reperfusion Injury/mortality , Survival Rate
7.
Biochemistry (Mosc) ; 84(6): 637-643, 2019 Jun.
Article in English | MEDLINE | ID: mdl-31238863

ABSTRACT

Taking into account a special role of pancreatic ß-cells in the development of diabetes mellitus, the effects of peroxiredoxin 6 (Prx6) on the viability and functional activity of rat insulinoma RIN-m5F ß-cells were studied under diabetes-simulating conditions. For this purpose, the cells were cultured at elevated glucose concentrations or in the presence of pro-inflammatory cytokines (TNF-α and IL-1) known for their special role in the cytotoxic autoimmune response in diabetes. It was found that the increased glucose concentration of 23-43 mM caused death of 20-60% ß-cells. Prx6 added to cells significantly reduced the level of reactive oxygen species and protected the RIN-m5F ß-cells from hyperglycemia, reducing the death of these cells by several fold. A measurement of insulin secretion by the RIN-m5F ß-cells showed a significant stimulatory effect of Prx6 on the insulin-producing activity of pancreatic ß-cells. It should be noted that the stimulatory activity of Prx6 was detected during culturing the cells under both normal and unfavorable conditions. The regulation of the NF-κB signaling cascade could be one of the mechanisms of Prx6 action on ß-cells, in particular, through activation of RelA/p65 phosphorylation at Ser536.


Subject(s)
Cytokines/toxicity , Glucose/toxicity , Insulin-Secreting Cells/drug effects , Peroxiredoxin VI/physiology , Animals , Cell Death/physiology , Cell Line, Tumor , Cell Survival/physiology , Cytokines/metabolism , Glucose/metabolism , Inflammation Mediators/metabolism , Insulin/biosynthesis , Insulin/metabolism , Insulin-Secreting Cells/metabolism , Interleukin-1/metabolism , NF-kappa B/metabolism , Phosphorylation , Rats , Reactive Oxygen Species/metabolism , Signal Transduction , Tumor Necrosis Factor-alpha/metabolism
8.
Biochemistry (Mosc) ; 84(2): 79-100, 2019 Feb.
Article in English | MEDLINE | ID: mdl-31216969

ABSTRACT

Cancer cells experience strong oxidative stress caused by disorders in cell metabolism and action of external factors. For survival, cancer cells have developed a highly efficient system of antioxidant defense, some of the most important elements of which are peroxiredoxins (Prxs). Prxs are an evolutionarily ancient family of selenium-independent peroxidases that reduce a wide range of organic and inorganic hydroperoxides in the cell and the extracellular space. In addition, some Prxs exhibit chaperone and phospholipase activities. Prxs play an important role in the maintenance of the cell redox homeostasis; they prevent oxidation and aggregation of regulatory proteins, thereby affecting many cell signaling pathways. Prxs are involved in the regulation of cell growth, differentiation, and apoptosis. Due to their versatility and wide representation in all tissues and organs, Prxs participate in the development/suppression of many pathological conditions, among which cancer occupies a special place. This review focuses on the role of Prxs in the development of various forms of cancer. Understanding molecular mechanisms of Prx involvement in these processes will allow to develop new approaches to the prevention and treatment of cancer.


Subject(s)
Biocatalysis , Carcinogenesis/metabolism , Peroxiredoxins/metabolism , Signal Transduction , Carcinogenesis/chemistry , Humans , Peroxiredoxins/chemistry
9.
Dokl Biochem Biophys ; 485(1): 132-134, 2019 Mar.
Article in English | MEDLINE | ID: mdl-31201633

ABSTRACT

It was established that recombinant human peroxiredoxins (Prx1, Prx2, Prx4, and Prx6) inhibit natural dicarbonyls formed during free radical peroxidation of unsaturated lipids (malonic dialdehyde) and oxidative transformations of glucose (glyoxal and methylglyoxal). A possible role of the decrease in the activity of peroxiredoxins under oxidative and carbonyl stress is discussed as an important factor that triggers the molecular mechanisms of vascular wall damage in atherosclerosis and diabetes mellitus.


Subject(s)
Free Radicals/chemistry , Lipid Peroxidation , Oxidative Stress , Peroxiredoxins/chemistry , Pyruvaldehyde/chemistry , Humans
10.
Free Radic Biol Med ; 134: 76-86, 2019 04.
Article in English | MEDLINE | ID: mdl-30605715

ABSTRACT

A radioprotective effect of exogenous recombinant peroxiredoxin 2 (Prx2) was revealed and characterized using an animal model of whole body X-ray irradiation at sublethal and lethal doses. Prx2 belongs to an evolutionarily ancient family of peroxidases that are involved in enzymatic degradation of a wide variety of organic and inorganic hydroperoxides. Apart from that, the oxidized form of Prx2 also exhibits chaperone activity, thereby preventing protein misfolding and aggregation under oxidative stress. Intravenous administration of Prx2 in animals at a concentration of 20 µg/g 15 min before exposure to ionizing radiation contributes to a significantly higher survival rate, suppresses the development of leucopenia and thrombocytopenia, as well as protects the bone marrow cells from genome DNA damage. Moreover, injection of Prx2 leads to suppression of apoptosis, stimulates cell proliferation and results in a more rapid recovery of the cell redox state. Exogenous Prx2 neutralizes the effect of the priming dose on the second irradiation of the cells. The radioprotective properties of exogenous Prx2 are stipulated by its broad substrate peroxidase activity, chaperone activity in the oxidized state, and are also due to the signal-regulatory function of Prx2 mediated by the regulation of the level of hydroperoxides as well as via interaction with redox-sensitive regulatory proteins.


Subject(s)
Homeodomain Proteins/administration & dosage , Homeodomain Proteins/metabolism , Leukopenia/prevention & control , Oxidative Stress/physiology , Radiation, Ionizing , Radiation-Protective Agents/administration & dosage , Thrombocytopenia/prevention & control , Animals , Disease Models, Animal , Homeodomain Proteins/genetics , Leukopenia/etiology , Male , Mice , Oxidation-Reduction , Oxidative Stress/radiation effects , Thrombocytopenia/etiology
11.
Free Radic Res ; 51(2): 148-166, 2017 Feb.
Article in English | MEDLINE | ID: mdl-28142292

ABSTRACT

Peroxiredoxins are redox-sensing multifunctional enzymes, among them peroxiredoxin 6 (Prx6) can neutralize the most broadest range of hydroperoxides and play an important role in maintaining the redox homeostasis of the cell. In the present study, radioprotective and signaling regulatory effects of Prx6 were demonstrated and characterized. Intravenously administered exogenous Prx6 protects the organism of mice from the destructive action of ionizing radiation in the lethal dose range of 5-10 Gy. Dose reduction factor of 1.4 Prx6 injection reduces the severity of radiation-induced leuko- and thrombopenia in irradiated animals, also preventing the destruction of epithelial cells in the small intestine. Injecting exogenous Prx6 also as its mutated form of Prx6-C47S lacking peroxidase activity affects the expression of genes involved in antioxidant response, DNA reparation, apoptosis and inflammatory processes, in bone marrow cells both in intact animals and in those subjected to ionizing radiation. The radioprotective properties of Prx6 are based, on the one hand, on the capability for ROS neutralization, and on the other hand - on the potentiality for activation of reparation processes of the cell under oxidative stress conditions. Prx6 can be considered as a potentially perspective radioprotective agent for the reduction of risks from the damaging action of ionizing radiation on the mammalian organism.


Subject(s)
Gene Expression Regulation/drug effects , Oxidative Stress/drug effects , Peroxiredoxin VI/pharmacology , Radiation Tolerance/drug effects , Radiation-Protective Agents/pharmacology , Animals , Apoptosis/drug effects , Apoptosis/radiation effects , Cells, Cultured , Gene Expression Regulation/radiation effects , Intestine, Small/cytology , Intestine, Small/drug effects , Intestine, Small/radiation effects , Male , Mice , Oxidative Stress/radiation effects , RNA, Messenger/genetics , Reactive Oxygen Species , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction/drug effects , Signal Transduction/radiation effects , Survival Rate , X-Rays
12.
Biochemistry (Mosc) ; 81(4): 420-7, 2016 Apr.
Article in English | MEDLINE | ID: mdl-27293100

ABSTRACT

A chimeric gene construct encoding human peroxiredoxin 6 and Mn-superoxide dismutase from Escherichia coli was developed. Conditions for expression of the fusion protein in E. coli cell were optimized. Fusing of the enzymes into a single polypeptide chain with peroxiredoxin 6 at the N-terminus (PSH) did not affect their activities. On the contrary, the chimeric protein with reverse order of enzymes (SPH) was not obtained in a water-soluble active form. The active chimeric protein (PSH) exhibiting both peroxidase and superoxide dismutase activities was prepared and its physicochemical properties were characterized.


Subject(s)
Escherichia coli Proteins/metabolism , Escherichia coli/metabolism , Peroxiredoxin VI/metabolism , Recombinant Fusion Proteins/biosynthesis , Superoxide Dismutase/metabolism , Escherichia coli Proteins/genetics , Humans , Peroxiredoxin VI/genetics , Protein Stability , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/isolation & purification , Superoxide Dismutase/genetics , Temperature
13.
Dokl Biochem Biophys ; 467(1): 110-2, 2016 Mar.
Article in English | MEDLINE | ID: mdl-27193711

ABSTRACT

After injection of 20 mg/kg peroxiredoxin 6 to male Kv:SHK mice 15 min before X-ray irradiation in the range of lethal doses (7-10 Gy), the mice remained alive for 30 days, whereas the mortality of the control animals was 100%. In the irradiated animals, peroxiredoxin 6 decreased the severity of radiation-induced leucopenia, granulocytopenia, and thrombocytopenia, increased the number of blood corpuscles, and prevented the mass death of epithelial cells and the destruction of the small intestine. Thus, peroxiredoxin 6 can be regarded as a prophylactic radioprotective agent.


Subject(s)
Peroxiredoxin VI/pharmacology , Radiation Injuries, Experimental/drug therapy , Radiation-Protective Agents/pharmacology , Animals , Injections, Intravenous , Intestine, Small/drug effects , Intestine, Small/pathology , Intestine, Small/radiation effects , Male , Mice , Radiation Injuries, Experimental/pathology , Severity of Illness Index , Survival Analysis , X-Rays
14.
Mol Biol (Mosk) ; 50(2): 336-46, 2016.
Article in Russian | MEDLINE | ID: mdl-27239855

ABSTRACT

Reactive oxygen species (ROS) are produced via catabolic and anabolic processes during normal embryonic development, and ROS content in the cell is maintained at a certain level. Peroxiredoxins are a family of selenium-independent peroxidases and play a key role in maintaining redox homeostasis of the cell. In addition to regulating the ROS level, peroxiredoxins are involved in intracellular and intercellular signaling, cell differentiation, and tissue development. The time course of peroxiredoxin gene (prx1-6) expression was studied in Xenopus laevis during early ontogeny (Nieuwkoop and Faber stages 10-63). The highest expression level was observed for prx1 at these developmental stages. The prx1, prx3, and prx4 expression level changed most dramatically in response to oxidative stress artificially induced in X. laevis embryos. In X. laevis adults, prx1-6 were all intensely expressed in all organs examined, the prx1 expression level being the highest. The X. laevis prx1-6 genes were cloned and expressed in Escherichia coli, and physico-chemical characteristics were compared for the recombinant enzymes. The highest peroxidase activity and thermal stability were observed for Prx1 and Prx2. It was assumed that Prx1 plays a leading role in X. laevis early development.


Subject(s)
Homeodomain Proteins/genetics , Oxidative Stress/genetics , Peroxidases/genetics , Peroxiredoxins/genetics , Xenopus Proteins/genetics , Xenopus laevis/growth & development , Animals , Cytoplasm/genetics , Embryo, Nonmammalian , Embryonic Development/genetics , Enzyme Stability , Gene Expression Regulation, Developmental , Peroxidases/biosynthesis , Peroxidases/chemistry , Peroxiredoxins/biosynthesis , Peroxiredoxins/chemistry , Reactive Oxygen Species/metabolism , Xenopus laevis/genetics
15.
Bull Exp Biol Med ; 160(5): 639-42, 2016 Mar.
Article in English | MEDLINE | ID: mdl-27021100

ABSTRACT

Antioxidant properties of recombinant peroxiredoxin-6 and chimeric protein PSH combining peroxidase and superoxide dismutase activities were studied on the model of retrograde perfusion of isolated rat heart under conditions of H2O2-induced oxidative stress. The exogenous antioxidant proteins exhibited cardioprotective properties manifested in heart rate normalization, maintenance of contractile activity of the myocardium, and prevention of H2O2-induced LPO in oxidative stress. Localization of peroxiredoxin-6 and PSH in the cardiac tissue was determined and myocardial structures most effectively protected by the antioxidant enzymes from ischemia/reperfusion-induced damages were identified. The results suggest that modified peroxiredoxins are promising components of perfusion media for preservation of isolated organs.


Subject(s)
Antioxidants/therapeutic use , Cardiotonic Agents/therapeutic use , Myocardial Reperfusion Injury/drug therapy , Myocardial Reperfusion Injury/prevention & control , Oxidative Stress/drug effects , Peroxiredoxins/therapeutic use , Animals , Heart/physiopathology , Heart Rate/drug effects , Hydrogen Peroxide/adverse effects , Male , Myocardial Contraction/drug effects , Perfusion , Peroxidase/metabolism , Rats , Rats, Wistar , Superoxide Dismutase/metabolism
16.
Bull Exp Biol Med ; 160(3): 322-6, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26742734

ABSTRACT

Nephroprotective effect of exogenous chimeric antioxidant enzyme with combined superoxide dismutase and peroxide activities (PSH protein) was studied on the model of ischemia/reperfusion damage of the renal tissue. It was shown that post-ischemic (25- and 45-min ischemia) intravenous administration of PSH protein significantly normalized the levels of creatinine and urea. Histological studies showed that as distinct from ischemic kidney, the structure of renal corpuscles and tubules remained unchanged, the number of atrophied glomeruli and glomeruli with exudates and protein inclusions decreased in the capsular teeth after postischemic intravenous administration of PSH protein. Immunohistochemical investigations showed that post-ischemic intravenous injection of PSH protein significantly reduced the intensity of apoptosis in ischemic renal tissues.


Subject(s)
Antioxidants/therapeutic use , Kidney/drug effects , Animals , Kidney/metabolism , Male , Peroxiredoxins/therapeutic use , Rats , Reperfusion Injury/drug therapy , Reperfusion Injury/metabolism , Superoxide Dismutase/therapeutic use
17.
Dokl Biochem Biophys ; 471(1): 410-412, 2016 Nov.
Article in English | MEDLINE | ID: mdl-28058676

ABSTRACT

It is shown that endothelial cells from human umbilical vein have a reduced activity and gene expression of the "classic" antioxidant enzymes (Cu,Zn-superoxide dismutase, catalase, and Se-containing glutathione peroxidase). At the same time, a high expression level of peroxiredoxin genes was identified in the same endothelial cells, which obviously indicates the predominant involvement of these enzymes in protecting the endothelium from the damaging effect of free radical peroxidation.


Subject(s)
Catalase/metabolism , Endothelial Cells/enzymology , Erythrocytes/enzymology , Glutathione Peroxidase/metabolism , Superoxide Dismutase-1/metabolism , Umbilical Veins/enzymology , Cells, Cultured , Gene Expression , Humans , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , Umbilical Veins/cytology
18.
Biofizika ; 60(4): 696-9, 2015.
Article in Russian | MEDLINE | ID: mdl-26394468

ABSTRACT

The antioxidant enzyme peroxiredoxin 6 forms cation selective ion cluster-type channels in the lipid bilayer. Channel clustering as oligomeric structure consists of three or more subunits--channels with conductance of about 350 pS in the 200 mM KCl. Mean dwell time of the channel's open states decreases with increasing membrane voltage. A possible molecular mechanism of the observed potential-dependent inactivation of the channel cluster is discussed.


Subject(s)
Ion Channels/chemistry , Lipid Bilayers/chemistry , Membrane Potentials , Peroxiredoxin VI/chemistry , Protein Subunits/chemistry , Cations, Monovalent , Chlorides/chemistry , Electric Conductivity , Humans , Ion Channel Gating , Kinetics , Phosphatidylcholines/chemistry , Potassium/chemistry , Recombinant Proteins/chemistry
19.
Dig Dis Sci ; 60(12): 3610-9, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26233545

ABSTRACT

BACKGROUND: Strong oxidative stress starting in the epithelium upon restoration of blood cell circulation is a major cause of necrosis of the intestinal epithelium in ischemia/reperfusion-induced damage. AIM: The purpose of this study was to investigate the tissue-protective effect of exogenous peroxiredoxin 6 (Prx6) in ischemia/reperfusion-induced damage of small intestine. METHODS: The research was carried out using a model of acute superior mesenteric artery occlusion in Wistar male rats. Exogenous Prx6 was administrated intravenously 15 min prior to small intestine ischemia. The distribution of endogenous Prx6 in the small intestine was determined by immunohistochemical analysis. The expression level of antioxidant enzymes was evaluated by RT-PCR in real time. RESULTS: Exogenous Prx6 injected to animals intravenously was detected in blood vessel lumens, and its diffuse distribution was subsequently confirmed in the intestinal epithelium. Expression analysis of genes coding for major antioxidant enzymes demonstrated a significant activation of SOD 1, SOD 3, Prx6, GPx2, GPx7 expression during I/R-induced damage of the small intestine. Injection of exogenous Prx6 prior to induced ischemia resulted in minimization of oxidative injury by reducing necrosis and apoptosis, by normalization of gene activity of antioxidant enzyme. It eventually led to a reduction of epithelium destruction in the small intestine. By contrast, administration of a purified mutant form of Prx6 (Prx6C47S) without peroxidase activity had no protective effect. CONCLUSION: The application of exogenous Prx6 enables normalization of the antioxidant status of the small intestine and reduction of cell destruction upon I/R-induced organ damage.


Subject(s)
Intestine, Small/pathology , Peroxiredoxin VI/pharmacology , Reperfusion Injury/prevention & control , Animals , Antioxidants/metabolism , Caspase 3/genetics , Caspase 3/metabolism , Enzyme-Linked Immunosorbent Assay , Enzymes/genetics , Enzymes/metabolism , Gene Expression Regulation, Enzymologic/drug effects , Immunohistochemistry , Intestine, Small/metabolism , Male , Mutation , Oxidative Stress , Peroxiredoxin VI/administration & dosage , Peroxiredoxin VI/pharmacokinetics , Rats , Rats, Wistar , Reactive Oxygen Species , Reperfusion Injury/metabolism
20.
Mol Biol (Mosk) ; 48(4): 600-28, 2014.
Article in Russian | MEDLINE | ID: mdl-25842845

ABSTRACT

Peroxiredoxins are evolutionarily ancient, but relatively recently discovered group of seleniumindependent peroxidases. Peroxiredoxins protect cells from various peroxides and play an important role in maintaining the oxidation-reduction homeostasis. Moreover, they are involved in many cellular processes that are not related to peroxidase activity. Here, recent data on the structure and function of peroxiredoxins, regulation of gene expression and activity of different peroxiredoxins are considered.


Subject(s)
Peroxiredoxins/chemistry , Peroxiredoxins/metabolism , Amino Acid Sequence , Animals , Archaea/enzymology , Gene Expression Regulation, Enzymologic , Insecta/enzymology , Mammals/metabolism , Molecular Sequence Data , Multifunctional Enzymes/metabolism , Oxidation-Reduction , Peroxiredoxins/genetics , Plants/enzymology , Prokaryotic Cells/enzymology , Protein Conformation , Protein Processing, Post-Translational , Sequence Homology, Amino Acid , Yeasts/enzymology
SELECTION OF CITATIONS
SEARCH DETAIL
...